99 related articles for article (PubMed ID: 3647850)
1. Evaluation of the minimal bactericidal time (MBT) of sulbenicillin against multiresistant pathogens.
Debbia E; Pesce A; Schito GC
Chemioterapia; 1987 Apr; 6(2):85-7. PubMed ID: 3647850
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity in vitro of sulbenicillin against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
Eftimiadi C; De Leo C; Schito GC
Drugs Exp Clin Res; 1985; 11(4):241-5. PubMed ID: 3939120
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity of a new synthetic penicillin: sodium sulbenicillin].
Costa AL; Monforte MT; Cusumano V; Zamboni C
Clin Ter; 1984 Jun; 109(6):557-61. PubMed ID: 6236946
[No Abstract] [Full Text] [Related]
4. [Bactericidal and potent antiadhesive activity of sulbenicillin].
Amato G; Nani E; Covelli B; Mattina R; Cocuzza G; Pappalardo C; Chisari G; Lo Bue AM; Gismondo MR; Nicoletti G
G Batteriol Virol Immunol; 1986; 79(7-12):204-15. PubMed ID: 3135222
[TBL] [Abstract][Full Text] [Related]
5. Bacteriological and clinical studies of sulbenicillin.
Kjellander J; Lanner A; Norrby R
Scand J Infect Dis; 1978; 10(3):235-41. PubMed ID: 362518
[TBL] [Abstract][Full Text] [Related]
6. [Restudies on antibacterial activity of sulbenicillin against anaerobic bacteria (author's transl)].
Umemura A; Isono M; Yamada N; Kobayashi T; Watanabe K; Ueno K
Jpn J Antibiot; 1981 Jun; 34(6):976-9. PubMed ID: 7026824
[No Abstract] [Full Text] [Related]
7. [Antibacterial activity of sulfobenzylpenicillin against anaerobic bacteria (author's transl)].
Ueno K; Ninomiya K; Watanabe K; Murata K
Jpn J Antibiot; 1979 Apr; 32(4):516-9. PubMed ID: 313459
[No Abstract] [Full Text] [Related]
8. Comparative in vitro activities of SCE-129, sulbenicillin, gentamicin, and dibekacin against Pseudomonas.
Tsuchiya K; Kondo M
Antimicrob Agents Chemother; 1978 Mar; 13(3):536-9. PubMed ID: 122528
[TBL] [Abstract][Full Text] [Related]
9. Acidity and intestinal bacteria: an in-vitro assessment of the bactericidal activity of hydrochloric acid on intestinal pathogens.
Rotimi VO; Egwari L; Akande B
Afr J Med Med Sci; 1990 Dec; 19(4):275-80. PubMed ID: 2127996
[TBL] [Abstract][Full Text] [Related]
10. [Morphology of Pseudomonas aeruginosa altered by antibiotic effect of sulbenicillin].
Obana Y; Nakazawa S
Nihon Saikingaku Zasshi; 1977 Mar; 32(2):337-43. PubMed ID: 406433
[No Abstract] [Full Text] [Related]
11. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Machka K; Dickert H; Braveny I
Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
Gatti M; Varoli O; Piscolla F
J Chemother; 1989 Jul; 1(4 Suppl):103-4. PubMed ID: 16312324
[No Abstract] [Full Text] [Related]
13. In vitro activity of piperacillin and other microbials on 491 bacterial isolates.
Reeves DS
Arch Intern Med; 1982 Oct; 142(11):2023-32. PubMed ID: 6215009
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of cefquinome against equine bacterial pathogens.
Thomas E; Thomas V; Wilhelm C
Vet Microbiol; 2006 Jun; 115(1-3):140-7. PubMed ID: 16455213
[TBL] [Abstract][Full Text] [Related]
15. [Various characteristics of Pseudomonas elongated by the action of synthetic penicillins].
Obana Y; Kuroda H; Nakazawa S
Nihon Saikingaku Zasshi; 1975 Jan; 30(1):108. PubMed ID: 814341
[No Abstract] [Full Text] [Related]
16. Inhibition of platelet function by sulbenicillin and its metabolite.
Ikeda Y; Kikuchi M; Matsuda S; Toyama K; Hasegawa M; Watanabe K; Ando Y
Antimicrob Agents Chemother; 1978 May; 13(5):881-3. PubMed ID: 666307
[TBL] [Abstract][Full Text] [Related]
17. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
Quentin C; Sageaux JC; Bebear C; Latrille J
Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
[TBL] [Abstract][Full Text] [Related]
18. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activity of the combination of cefoperazone piperacillin].
Krüger E; Machka K; Braveny I
Arzneimittelforschung; 1983; 33(4):571-4. PubMed ID: 6223645
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
